Want to join the conversation?
Biotechnology company $ACOR said the US Patent and Trademark Office's Patent Trials and Appeal Board (PTAB) has instituted the inter partes review (IPR) of Patent Nos. 685, 703, 437 and 826. Ruling on the IPR petition is expected in one year.
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.